Novartis Institutes for BioMedical Research, Novartis Pharma AG, Forum 1 Novartis Campus, CH-4056 Basel, Switzerland.
Drug Discov Today. 2013 Sep;18(17-18):843-52. doi: 10.1016/j.drudis.2013.05.008. Epub 2013 May 20.
Molecular information systems play an important part in modern data-driven drug discovery. They do not only support decision making but also enable new discoveries via association and inference. In this review, we outline the scientific requirements identified by the Innovative Medicines Initiative (IMI) Open PHACTS consortium for the design of an open pharmacological space (OPS) information system. The focus of this work is the integration of compound-target-pathway-disease/phenotype data for public and industrial drug discovery research. Typical scientific competency questions provided by the consortium members will be analyzed based on the underlying data concepts and associations needed to answer the questions. Publicly available data sources used to target these questions as well as the need for and potential of semantic web-based technology will be presented.
分子信息系统在现代数据驱动的药物发现中起着重要的作用。它们不仅支持决策,还通过关联和推理实现新的发现。在这篇综述中,我们概述了创新药物倡议(IMI)开放式 PHACTS 联盟为设计开放式药理空间(OPS)信息系统而确定的科学要求。这项工作的重点是整合化合物-靶标-途径-疾病/表型数据,用于公共和工业药物发现研究。将根据回答这些问题所需的基础数据概念和关联来分析联盟成员提供的典型科学能力问题。还将介绍用于针对这些问题的公开可用数据源,以及基于语义网技术的需求和潜力。